45
Renue Life Sciences raises $3M in first biotech capital round
Company raise · Raising · SAN CARLOS, CA · Form D filed 2026-10-14
Renue Life Sciences, a Delaware biotech corporation incorporated in 2026, is raising $3M under Regulation D exemption 6(b). The company has sold $250K to 8 investors so far and is based in San Carlos, California.
Note: Company incorporated in 2026 and filed Form D in October 2026; first sale was October 2, 2026—very early stage. No placement agent listed.
First raise on EDGARoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Samuel David Perli | Executive Officer, Director, Promoter |
| Phanidhar Kukutla | Executive Officer, Director, Promoter |
| Jean-Louis Lelogeais | Director |
Signed by Phanidhar Kukutla, Treasurer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.